The stock has been on a steady climb since the beginning of the year, with a 12-month high of $0.45. The company’s recent surge in share price can be attributed to several factors, including its strong financial performance, positive investor sentiment, and a favorable market environment. Novo Integrated Sciences, Inc. is a leading provider of innovative and sustainable solutions for the pharmaceutical and biotechnology industries. The company’s core business is focused on the development, manufacturing, and commercialization of high-quality, cost-effective, and environmentally friendly products. has a strong track record of success in the pharmaceutical and biotechnology industries.

The Healthcare Services segment focuses on providing primary care services, including physician visits, diagnostic testing, and treatment plans. The Product Sales segment focuses on selling wellness products and services, such as vitamins, supplements, and fitness equipment. Novo Integrated Sciences is a privately held company headquartered in Toronto, Ontario, Canada. It was founded in 2008 and has a strong commitment to innovation and customer satisfaction. The company’s mission is to empower individuals to achieve optimal health and wellness through its integrated approach to healthcare and wellness.